The goal of this research is to determine if DetectnetTM PET/CT can be used to make Lutathera therapy safer for patients with neuroendocrine cancer. Participants will: * Complete two phases involving 6 visits * Undergo additional research PET/CT, and possibly SPECT/CT scans
Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor
The goal of this research is to determine if DetectnetTM PET/CT can be used to make Lutathera therapy safer for patients with neuroendocrine cancer. Participants will: * Complete two phases involving 6 visits * Undergo additional research PET/CT, and possibly SPECT/CT scans
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
-
University of Wisconsin - Madison, Madison, Wisconsin, United States, 53705
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
University of Wisconsin, Madison,
Steve Cho, MD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison
2025-04